API Derivatives Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of API Derivatives in Global, including the following market information:
Global API Derivatives Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global API Derivatives market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amine Derivatives Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of API Derivatives include Dishman Carbogen Amcis Limited, Sanofi Cepia, Yangzhou Prince Pharmaceutical Technology Co., Ltd., Shanghai Haoyuan Pharmaceutical Co., Ltd., Wuhan Yuanda Hongyuan Co., Ltd., Hunan Huateng Pharmaceutical Co., Ltd., Hubei Bafeng Pharmaceutical Co., Ltd., Co-operative Pharmaceutical and Jiangsu Zhongbang Pharmaceutical Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the API Derivatives companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global API Derivatives Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global API Derivatives Market Segment Percentages, by Type, 2021 (%)
Global API Derivatives Market Segment Percentages, by Application, 2021 (%)
Global API Derivatives Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies API Derivatives revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies API Derivatives revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global API Derivatives Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global API Derivatives market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amine Derivatives Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of API Derivatives include Dishman Carbogen Amcis Limited, Sanofi Cepia, Yangzhou Prince Pharmaceutical Technology Co., Ltd., Shanghai Haoyuan Pharmaceutical Co., Ltd., Wuhan Yuanda Hongyuan Co., Ltd., Hunan Huateng Pharmaceutical Co., Ltd., Hubei Bafeng Pharmaceutical Co., Ltd., Co-operative Pharmaceutical and Jiangsu Zhongbang Pharmaceutical Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the API Derivatives companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global API Derivatives Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global API Derivatives Market Segment Percentages, by Type, 2021 (%)
- Amine Derivatives
- Ether Derivatives
- Pyridine Derivatives
- Vitamin Derivatives
- Other
Global API Derivatives Market Segment Percentages, by Application, 2021 (%)
- Diabetes Medication
- Blood Tube Drugs
- Painkillers
- Psychotropic Drugs
- Nutritional Calcium Drugs
- Oncology Drugs
- Other
Global API Derivatives Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies API Derivatives revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies API Derivatives revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Dishman Carbogen Amcis Limited
- Sanofi Cepia
- Yangzhou Prince Pharmaceutical Technology Co., Ltd.
- Shanghai Haoyuan Pharmaceutical Co., Ltd.
- Wuhan Yuanda Hongyuan Co., Ltd.
- Hunan Huateng Pharmaceutical Co., Ltd.
- Hubei Bafeng Pharmaceutical Co., Ltd.
- Co-operative Pharmaceutical
- Jiangsu Zhongbang Pharmaceutical Co., Ltd.
- Xinyu Pharmaceutical Co., Ltd.
- Vinda Chemical
- Huzhou Zhanwang Pharmaceutical Co., Ltd.
- Suzhou Fujilai Pharmaceutical Co., Ltd.
- Hongyuan Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 API Derivatives Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global API Derivatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL API DERIVATIVES OVERALL MARKET SIZE
2.1 Global API Derivatives Market Size: 2021 VS 2028
2.2 Global API Derivatives Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top API Derivatives Players in Global Market
3.2 Top Global API Derivatives Companies Ranked by Revenue
3.3 Global API Derivatives Revenue by Companies
3.4 Top 3 and Top 5 API Derivatives Companies in Global Market, by Revenue in 2021
3.5 Global Companies API Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 API Derivatives Players in Global Market
3.6.1 List of Global Tier 1 API Derivatives Companies
3.6.2 List of Global Tier 2 and Tier 3 API Derivatives Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global API Derivatives Market Size Markets, 2021 & 2028
4.1.2 Amine Derivatives
4.1.3 Ether Derivatives
4.1.4 Pyridine Derivatives
4.1.5 Vitamin Derivatives
4.1.6 Other
4.2 By Type - Global API Derivatives Revenue & Forecasts
4.2.1 By Type - Global API Derivatives Revenue, 2017-2022
4.2.2 By Type - Global API Derivatives Revenue, 2023-2028
4.2.3 By Type - Global API Derivatives Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global API Derivatives Market Size, 2021 & 2028
5.1.2 Diabetes Medication
5.1.3 Blood Tube Drugs
5.1.4 Painkillers
5.1.5 Psychotropic Drugs
5.1.6 Nutritional Calcium Drugs
5.1.7 Oncology Drugs
5.1.8 Other
5.2 By Application - Global API Derivatives Revenue & Forecasts
5.2.1 By Application - Global API Derivatives Revenue, 2017-2022
5.2.2 By Application - Global API Derivatives Revenue, 2023-2028
5.2.3 By Application - Global API Derivatives Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global API Derivatives Market Size, 2021 & 2028
6.2 By Region - Global API Derivatives Revenue & Forecasts
6.2.1 By Region - Global API Derivatives Revenue, 2017-2022
6.2.2 By Region - Global API Derivatives Revenue, 2023-2028
6.2.3 By Region - Global API Derivatives Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America API Derivatives Revenue, 2017-2028
6.3.2 US API Derivatives Market Size, 2017-2028
6.3.3 Canada API Derivatives Market Size, 2017-2028
6.3.4 Mexico API Derivatives Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe API Derivatives Revenue, 2017-2028
6.4.2 Germany API Derivatives Market Size, 2017-2028
6.4.3 France API Derivatives Market Size, 2017-2028
6.4.4 U.K. API Derivatives Market Size, 2017-2028
6.4.5 Italy API Derivatives Market Size, 2017-2028
6.4.6 Russia API Derivatives Market Size, 2017-2028
6.4.7 Nordic Countries API Derivatives Market Size, 2017-2028
6.4.8 Benelux API Derivatives Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia API Derivatives Revenue, 2017-2028
6.5.2 China API Derivatives Market Size, 2017-2028
6.5.3 Japan API Derivatives Market Size, 2017-2028
6.5.4 South Korea API Derivatives Market Size, 2017-2028
6.5.5 Southeast Asia API Derivatives Market Size, 2017-2028
6.5.6 India API Derivatives Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America API Derivatives Revenue, 2017-2028
6.6.2 Brazil API Derivatives Market Size, 2017-2028
6.6.3 Argentina API Derivatives Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa API Derivatives Revenue, 2017-2028
6.7.2 Turkey API Derivatives Market Size, 2017-2028
6.7.3 Israel API Derivatives Market Size, 2017-2028
6.7.4 Saudi Arabia API Derivatives Market Size, 2017-2028
6.7.5 UAE API Derivatives Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Dishman Carbogen Amcis Limited
7.1.1 Dishman Carbogen Amcis Limited Corporate Summary
7.1.2 Dishman Carbogen Amcis Limited Business Overview
7.1.3 Dishman Carbogen Amcis Limited API Derivatives Major Product Offerings
7.1.4 Dishman Carbogen Amcis Limited API Derivatives Revenue in Global Market (2017-2022)
7.1.5 Dishman Carbogen Amcis Limited Key News
7.2 Sanofi Cepia
7.2.1 Sanofi Cepia Corporate Summary
7.2.2 Sanofi Cepia Business Overview
7.2.3 Sanofi Cepia API Derivatives Major Product Offerings
7.2.4 Sanofi Cepia API Derivatives Revenue in Global Market (2017-2022)
7.2.5 Sanofi Cepia Key News
7.3 Yangzhou Prince Pharmaceutical Technology Co., Ltd.
7.3.1 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Corporate Summary
7.3.2 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Business Overview
7.3.3 Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Major Product Offerings
7.3.4 Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.3.5 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Key News
7.4 Shanghai Haoyuan Pharmaceutical Co., Ltd.
7.4.1 Shanghai Haoyuan Pharmaceutical Co., Ltd. Corporate Summary
7.4.2 Shanghai Haoyuan Pharmaceutical Co., Ltd. Business Overview
7.4.3 Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.4.4 Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.4.5 Shanghai Haoyuan Pharmaceutical Co., Ltd. Key News
7.5 Wuhan Yuanda Hongyuan Co., Ltd.
7.5.1 Wuhan Yuanda Hongyuan Co., Ltd. Corporate Summary
7.5.2 Wuhan Yuanda Hongyuan Co., Ltd. Business Overview
7.5.3 Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Major Product Offerings
7.5.4 Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.5.5 Wuhan Yuanda Hongyuan Co., Ltd. Key News
7.6 Hunan Huateng Pharmaceutical Co., Ltd.
7.6.1 Hunan Huateng Pharmaceutical Co., Ltd. Corporate Summary
7.6.2 Hunan Huateng Pharmaceutical Co., Ltd. Business Overview
7.6.3 Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.6.4 Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.6.5 Hunan Huateng Pharmaceutical Co., Ltd. Key News
7.7 Hubei Bafeng Pharmaceutical Co., Ltd.
7.7.1 Hubei Bafeng Pharmaceutical Co., Ltd. Corporate Summary
7.7.2 Hubei Bafeng Pharmaceutical Co., Ltd. Business Overview
7.7.3 Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.7.4 Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.7.5 Hubei Bafeng Pharmaceutical Co., Ltd. Key News
7.8 Co-operative Pharmaceutical
7.8.1 Co-operative Pharmaceutical Corporate Summary
7.8.2 Co-operative Pharmaceutical Business Overview
7.8.3 Co-operative Pharmaceutical API Derivatives Major Product Offerings
7.8.4 Co-operative Pharmaceutical API Derivatives Revenue in Global Market (2017-2022)
7.8.5 Co-operative Pharmaceutical Key News
7.9 Jiangsu Zhongbang Pharmaceutical Co., Ltd.
7.9.1 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Corporate Summary
7.9.2 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Business Overview
7.9.3 Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.9.4 Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.9.5 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Key News
7.10 Xinyu Pharmaceutical Co., Ltd.
7.10.1 Xinyu Pharmaceutical Co., Ltd. Corporate Summary
7.10.2 Xinyu Pharmaceutical Co., Ltd. Business Overview
7.10.3 Xinyu Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.10.4 Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.10.5 Xinyu Pharmaceutical Co., Ltd. Key News
7.11 Vinda Chemical
7.11.1 Vinda Chemical Corporate Summary
7.11.2 Vinda Chemical Business Overview
7.11.3 Vinda Chemical API Derivatives Major Product Offerings
7.11.4 Vinda Chemical API Derivatives Revenue in Global Market (2017-2022)
7.11.5 Vinda Chemical Key News
7.12 Huzhou Zhanwang Pharmaceutical Co., Ltd.
7.12.1 Huzhou Zhanwang Pharmaceutical Co., Ltd. Corporate Summary
7.12.2 Huzhou Zhanwang Pharmaceutical Co., Ltd. Business Overview
7.12.3 Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.12.4 Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.12.5 Huzhou Zhanwang Pharmaceutical Co., Ltd. Key News
7.13 Suzhou Fujilai Pharmaceutical Co., Ltd.
7.13.1 Suzhou Fujilai Pharmaceutical Co., Ltd. Corporate Summary
7.13.2 Suzhou Fujilai Pharmaceutical Co., Ltd. Business Overview
7.13.3 Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.13.4 Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.13.5 Suzhou Fujilai Pharmaceutical Co., Ltd. Key News
7.14 Hongyuan Pharmaceutical
7.14.1 Hongyuan Pharmaceutical Corporate Summary
7.14.2 Hongyuan Pharmaceutical Business Overview
7.14.3 Hongyuan Pharmaceutical API Derivatives Major Product Offerings
7.14.4 Hongyuan Pharmaceutical API Derivatives Revenue in Global Market (2017-2022)
7.14.5 Hongyuan Pharmaceutical Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 API Derivatives Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global API Derivatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL API DERIVATIVES OVERALL MARKET SIZE
2.1 Global API Derivatives Market Size: 2021 VS 2028
2.2 Global API Derivatives Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top API Derivatives Players in Global Market
3.2 Top Global API Derivatives Companies Ranked by Revenue
3.3 Global API Derivatives Revenue by Companies
3.4 Top 3 and Top 5 API Derivatives Companies in Global Market, by Revenue in 2021
3.5 Global Companies API Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 API Derivatives Players in Global Market
3.6.1 List of Global Tier 1 API Derivatives Companies
3.6.2 List of Global Tier 2 and Tier 3 API Derivatives Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global API Derivatives Market Size Markets, 2021 & 2028
4.1.2 Amine Derivatives
4.1.3 Ether Derivatives
4.1.4 Pyridine Derivatives
4.1.5 Vitamin Derivatives
4.1.6 Other
4.2 By Type - Global API Derivatives Revenue & Forecasts
4.2.1 By Type - Global API Derivatives Revenue, 2017-2022
4.2.2 By Type - Global API Derivatives Revenue, 2023-2028
4.2.3 By Type - Global API Derivatives Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global API Derivatives Market Size, 2021 & 2028
5.1.2 Diabetes Medication
5.1.3 Blood Tube Drugs
5.1.4 Painkillers
5.1.5 Psychotropic Drugs
5.1.6 Nutritional Calcium Drugs
5.1.7 Oncology Drugs
5.1.8 Other
5.2 By Application - Global API Derivatives Revenue & Forecasts
5.2.1 By Application - Global API Derivatives Revenue, 2017-2022
5.2.2 By Application - Global API Derivatives Revenue, 2023-2028
5.2.3 By Application - Global API Derivatives Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global API Derivatives Market Size, 2021 & 2028
6.2 By Region - Global API Derivatives Revenue & Forecasts
6.2.1 By Region - Global API Derivatives Revenue, 2017-2022
6.2.2 By Region - Global API Derivatives Revenue, 2023-2028
6.2.3 By Region - Global API Derivatives Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America API Derivatives Revenue, 2017-2028
6.3.2 US API Derivatives Market Size, 2017-2028
6.3.3 Canada API Derivatives Market Size, 2017-2028
6.3.4 Mexico API Derivatives Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe API Derivatives Revenue, 2017-2028
6.4.2 Germany API Derivatives Market Size, 2017-2028
6.4.3 France API Derivatives Market Size, 2017-2028
6.4.4 U.K. API Derivatives Market Size, 2017-2028
6.4.5 Italy API Derivatives Market Size, 2017-2028
6.4.6 Russia API Derivatives Market Size, 2017-2028
6.4.7 Nordic Countries API Derivatives Market Size, 2017-2028
6.4.8 Benelux API Derivatives Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia API Derivatives Revenue, 2017-2028
6.5.2 China API Derivatives Market Size, 2017-2028
6.5.3 Japan API Derivatives Market Size, 2017-2028
6.5.4 South Korea API Derivatives Market Size, 2017-2028
6.5.5 Southeast Asia API Derivatives Market Size, 2017-2028
6.5.6 India API Derivatives Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America API Derivatives Revenue, 2017-2028
6.6.2 Brazil API Derivatives Market Size, 2017-2028
6.6.3 Argentina API Derivatives Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa API Derivatives Revenue, 2017-2028
6.7.2 Turkey API Derivatives Market Size, 2017-2028
6.7.3 Israel API Derivatives Market Size, 2017-2028
6.7.4 Saudi Arabia API Derivatives Market Size, 2017-2028
6.7.5 UAE API Derivatives Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Dishman Carbogen Amcis Limited
7.1.1 Dishman Carbogen Amcis Limited Corporate Summary
7.1.2 Dishman Carbogen Amcis Limited Business Overview
7.1.3 Dishman Carbogen Amcis Limited API Derivatives Major Product Offerings
7.1.4 Dishman Carbogen Amcis Limited API Derivatives Revenue in Global Market (2017-2022)
7.1.5 Dishman Carbogen Amcis Limited Key News
7.2 Sanofi Cepia
7.2.1 Sanofi Cepia Corporate Summary
7.2.2 Sanofi Cepia Business Overview
7.2.3 Sanofi Cepia API Derivatives Major Product Offerings
7.2.4 Sanofi Cepia API Derivatives Revenue in Global Market (2017-2022)
7.2.5 Sanofi Cepia Key News
7.3 Yangzhou Prince Pharmaceutical Technology Co., Ltd.
7.3.1 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Corporate Summary
7.3.2 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Business Overview
7.3.3 Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Major Product Offerings
7.3.4 Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.3.5 Yangzhou Prince Pharmaceutical Technology Co., Ltd. Key News
7.4 Shanghai Haoyuan Pharmaceutical Co., Ltd.
7.4.1 Shanghai Haoyuan Pharmaceutical Co., Ltd. Corporate Summary
7.4.2 Shanghai Haoyuan Pharmaceutical Co., Ltd. Business Overview
7.4.3 Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.4.4 Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.4.5 Shanghai Haoyuan Pharmaceutical Co., Ltd. Key News
7.5 Wuhan Yuanda Hongyuan Co., Ltd.
7.5.1 Wuhan Yuanda Hongyuan Co., Ltd. Corporate Summary
7.5.2 Wuhan Yuanda Hongyuan Co., Ltd. Business Overview
7.5.3 Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Major Product Offerings
7.5.4 Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.5.5 Wuhan Yuanda Hongyuan Co., Ltd. Key News
7.6 Hunan Huateng Pharmaceutical Co., Ltd.
7.6.1 Hunan Huateng Pharmaceutical Co., Ltd. Corporate Summary
7.6.2 Hunan Huateng Pharmaceutical Co., Ltd. Business Overview
7.6.3 Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.6.4 Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.6.5 Hunan Huateng Pharmaceutical Co., Ltd. Key News
7.7 Hubei Bafeng Pharmaceutical Co., Ltd.
7.7.1 Hubei Bafeng Pharmaceutical Co., Ltd. Corporate Summary
7.7.2 Hubei Bafeng Pharmaceutical Co., Ltd. Business Overview
7.7.3 Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.7.4 Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.7.5 Hubei Bafeng Pharmaceutical Co., Ltd. Key News
7.8 Co-operative Pharmaceutical
7.8.1 Co-operative Pharmaceutical Corporate Summary
7.8.2 Co-operative Pharmaceutical Business Overview
7.8.3 Co-operative Pharmaceutical API Derivatives Major Product Offerings
7.8.4 Co-operative Pharmaceutical API Derivatives Revenue in Global Market (2017-2022)
7.8.5 Co-operative Pharmaceutical Key News
7.9 Jiangsu Zhongbang Pharmaceutical Co., Ltd.
7.9.1 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Corporate Summary
7.9.2 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Business Overview
7.9.3 Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.9.4 Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.9.5 Jiangsu Zhongbang Pharmaceutical Co., Ltd. Key News
7.10 Xinyu Pharmaceutical Co., Ltd.
7.10.1 Xinyu Pharmaceutical Co., Ltd. Corporate Summary
7.10.2 Xinyu Pharmaceutical Co., Ltd. Business Overview
7.10.3 Xinyu Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.10.4 Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.10.5 Xinyu Pharmaceutical Co., Ltd. Key News
7.11 Vinda Chemical
7.11.1 Vinda Chemical Corporate Summary
7.11.2 Vinda Chemical Business Overview
7.11.3 Vinda Chemical API Derivatives Major Product Offerings
7.11.4 Vinda Chemical API Derivatives Revenue in Global Market (2017-2022)
7.11.5 Vinda Chemical Key News
7.12 Huzhou Zhanwang Pharmaceutical Co., Ltd.
7.12.1 Huzhou Zhanwang Pharmaceutical Co., Ltd. Corporate Summary
7.12.2 Huzhou Zhanwang Pharmaceutical Co., Ltd. Business Overview
7.12.3 Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.12.4 Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.12.5 Huzhou Zhanwang Pharmaceutical Co., Ltd. Key News
7.13 Suzhou Fujilai Pharmaceutical Co., Ltd.
7.13.1 Suzhou Fujilai Pharmaceutical Co., Ltd. Corporate Summary
7.13.2 Suzhou Fujilai Pharmaceutical Co., Ltd. Business Overview
7.13.3 Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Major Product Offerings
7.13.4 Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue in Global Market (2017-2022)
7.13.5 Suzhou Fujilai Pharmaceutical Co., Ltd. Key News
7.14 Hongyuan Pharmaceutical
7.14.1 Hongyuan Pharmaceutical Corporate Summary
7.14.2 Hongyuan Pharmaceutical Business Overview
7.14.3 Hongyuan Pharmaceutical API Derivatives Major Product Offerings
7.14.4 Hongyuan Pharmaceutical API Derivatives Revenue in Global Market (2017-2022)
7.14.5 Hongyuan Pharmaceutical Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. API Derivatives Market Opportunities & Trends in Global Market
Table 2. API Derivatives Market Drivers in Global Market
Table 3. API Derivatives Market Restraints in Global Market
Table 4. Key Players of API Derivatives in Global Market
Table 5. Top API Derivatives Players in Global Market, Ranking by Revenue (2021)
Table 6. Global API Derivatives Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global API Derivatives Revenue Share by Companies, 2017-2022
Table 8. Global Companies API Derivatives Product Type
Table 9. List of Global Tier 1 API Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 API Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global API Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - API Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - API Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global API Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - API Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - API Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global API Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global API Derivatives Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global API Derivatives Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America API Derivatives Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America API Derivatives Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe API Derivatives Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe API Derivatives Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia API Derivatives Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia API Derivatives Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America API Derivatives Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America API Derivatives Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa API Derivatives Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa API Derivatives Revenue, (US$, Mn), 2023-2028
Table 30. Dishman Carbogen Amcis Limited Corporate Summary
Table 31. Dishman Carbogen Amcis Limited API Derivatives Product Offerings
Table 32. Dishman Carbogen Amcis Limited API Derivatives Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Cepia Corporate Summary
Table 34. Sanofi Cepia API Derivatives Product Offerings
Table 35. Sanofi Cepia API Derivatives Revenue (US$, Mn), (2017-2022)
Table 36. Yangzhou Prince Pharmaceutical Technology Co., Ltd. Corporate Summary
Table 37. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Product Offerings
Table 38. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 39. Shanghai Haoyuan Pharmaceutical Co., Ltd. Corporate Summary
Table 40. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 41. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 42. Wuhan Yuanda Hongyuan Co., Ltd. Corporate Summary
Table 43. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Product Offerings
Table 44. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 45. Hunan Huateng Pharmaceutical Co., Ltd. Corporate Summary
Table 46. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 47. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 48. Hubei Bafeng Pharmaceutical Co., Ltd. Corporate Summary
Table 49. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 50. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 51. Co-operative Pharmaceutical Corporate Summary
Table 52. Co-operative Pharmaceutical API Derivatives Product Offerings
Table 53. Co-operative Pharmaceutical API Derivatives Revenue (US$, Mn), (2017-2022)
Table 54. Jiangsu Zhongbang Pharmaceutical Co., Ltd. Corporate Summary
Table 55. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 56. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 57. Xinyu Pharmaceutical Co., Ltd. Corporate Summary
Table 58. Xinyu Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 59. Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 60. Vinda Chemical Corporate Summary
Table 61. Vinda Chemical API Derivatives Product Offerings
Table 62. Vinda Chemical API Derivatives Revenue (US$, Mn), (2017-2022)
Table 63. Huzhou Zhanwang Pharmaceutical Co., Ltd. Corporate Summary
Table 64. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 65. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 66. Suzhou Fujilai Pharmaceutical Co., Ltd. Corporate Summary
Table 67. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 68. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 69. Hongyuan Pharmaceutical Corporate Summary
Table 70. Hongyuan Pharmaceutical API Derivatives Product Offerings
Table 71. Hongyuan Pharmaceutical API Derivatives Revenue (US$, Mn), (2017-2022)
Table 1. API Derivatives Market Opportunities & Trends in Global Market
Table 2. API Derivatives Market Drivers in Global Market
Table 3. API Derivatives Market Restraints in Global Market
Table 4. Key Players of API Derivatives in Global Market
Table 5. Top API Derivatives Players in Global Market, Ranking by Revenue (2021)
Table 6. Global API Derivatives Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global API Derivatives Revenue Share by Companies, 2017-2022
Table 8. Global Companies API Derivatives Product Type
Table 9. List of Global Tier 1 API Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 API Derivatives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global API Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - API Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - API Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global API Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - API Derivatives Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - API Derivatives Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global API Derivatives Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global API Derivatives Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global API Derivatives Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America API Derivatives Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America API Derivatives Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe API Derivatives Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe API Derivatives Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia API Derivatives Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia API Derivatives Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America API Derivatives Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America API Derivatives Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa API Derivatives Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa API Derivatives Revenue, (US$, Mn), 2023-2028
Table 30. Dishman Carbogen Amcis Limited Corporate Summary
Table 31. Dishman Carbogen Amcis Limited API Derivatives Product Offerings
Table 32. Dishman Carbogen Amcis Limited API Derivatives Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Cepia Corporate Summary
Table 34. Sanofi Cepia API Derivatives Product Offerings
Table 35. Sanofi Cepia API Derivatives Revenue (US$, Mn), (2017-2022)
Table 36. Yangzhou Prince Pharmaceutical Technology Co., Ltd. Corporate Summary
Table 37. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Product Offerings
Table 38. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 39. Shanghai Haoyuan Pharmaceutical Co., Ltd. Corporate Summary
Table 40. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 41. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 42. Wuhan Yuanda Hongyuan Co., Ltd. Corporate Summary
Table 43. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Product Offerings
Table 44. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 45. Hunan Huateng Pharmaceutical Co., Ltd. Corporate Summary
Table 46. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 47. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 48. Hubei Bafeng Pharmaceutical Co., Ltd. Corporate Summary
Table 49. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 50. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 51. Co-operative Pharmaceutical Corporate Summary
Table 52. Co-operative Pharmaceutical API Derivatives Product Offerings
Table 53. Co-operative Pharmaceutical API Derivatives Revenue (US$, Mn), (2017-2022)
Table 54. Jiangsu Zhongbang Pharmaceutical Co., Ltd. Corporate Summary
Table 55. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 56. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 57. Xinyu Pharmaceutical Co., Ltd. Corporate Summary
Table 58. Xinyu Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 59. Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 60. Vinda Chemical Corporate Summary
Table 61. Vinda Chemical API Derivatives Product Offerings
Table 62. Vinda Chemical API Derivatives Revenue (US$, Mn), (2017-2022)
Table 63. Huzhou Zhanwang Pharmaceutical Co., Ltd. Corporate Summary
Table 64. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 65. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 66. Suzhou Fujilai Pharmaceutical Co., Ltd. Corporate Summary
Table 67. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Product Offerings
Table 68. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue (US$, Mn), (2017-2022)
Table 69. Hongyuan Pharmaceutical Corporate Summary
Table 70. Hongyuan Pharmaceutical API Derivatives Product Offerings
Table 71. Hongyuan Pharmaceutical API Derivatives Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. API Derivatives Segment by Type in 2021
Figure 2. API Derivatives Segment by Application in 2021
Figure 3. Global API Derivatives Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global API Derivatives Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global API Derivatives Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by API Derivatives Revenue in 2021
Figure 8. By Type - Global API Derivatives Revenue Market Share, 2017-2028
Figure 9. By Application - Global API Derivatives Revenue Market Share, 2017-2028
Figure 10. By Region - Global API Derivatives Revenue Market Share, 2017-2028
Figure 11. By Country - North America API Derivatives Revenue Market Share, 2017-2028
Figure 12. US API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 13. Canada API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe API Derivatives Revenue Market Share, 2017-2028
Figure 16. Germany API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 17. France API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 19. Italy API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 20. Russia API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia API Derivatives Revenue Market Share, 2017-2028
Figure 24. China API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 25. Japan API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 28. India API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America API Derivatives Revenue Market Share, 2017-2028
Figure 30. Brazil API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa API Derivatives Revenue Market Share, 2017-2028
Figure 33. Turkey API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 34. Israel API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 36. UAE API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 37. Dishman Carbogen Amcis Limited API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Cepia API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Co-operative Pharmaceutical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vinda Chemical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Hongyuan Pharmaceutical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. API Derivatives Segment by Type in 2021
Figure 2. API Derivatives Segment by Application in 2021
Figure 3. Global API Derivatives Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global API Derivatives Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global API Derivatives Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by API Derivatives Revenue in 2021
Figure 8. By Type - Global API Derivatives Revenue Market Share, 2017-2028
Figure 9. By Application - Global API Derivatives Revenue Market Share, 2017-2028
Figure 10. By Region - Global API Derivatives Revenue Market Share, 2017-2028
Figure 11. By Country - North America API Derivatives Revenue Market Share, 2017-2028
Figure 12. US API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 13. Canada API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe API Derivatives Revenue Market Share, 2017-2028
Figure 16. Germany API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 17. France API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 19. Italy API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 20. Russia API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia API Derivatives Revenue Market Share, 2017-2028
Figure 24. China API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 25. Japan API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 28. India API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America API Derivatives Revenue Market Share, 2017-2028
Figure 30. Brazil API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa API Derivatives Revenue Market Share, 2017-2028
Figure 33. Turkey API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 34. Israel API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 36. UAE API Derivatives Revenue, (US$, Mn), 2017-2028
Figure 37. Dishman Carbogen Amcis Limited API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Cepia API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Yangzhou Prince Pharmaceutical Technology Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Shanghai Haoyuan Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Wuhan Yuanda Hongyuan Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hunan Huateng Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hubei Bafeng Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Co-operative Pharmaceutical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Jiangsu Zhongbang Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Xinyu Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vinda Chemical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Huzhou Zhanwang Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Suzhou Fujilai Pharmaceutical Co., Ltd. API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Hongyuan Pharmaceutical API Derivatives Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
